Ginkgo Bioworks Holdings Bolsa (NYSE: DNA)

Ginkgo Bioworks Holdings (NYSE:DNA) Bolsa

Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AAMI

ACEL

AXON

CDNA

CLIK

ENVB

FLYW

HCTI

ICCT

LBTYK

LMND

NAMS

PITA

PRCH

SMCI

ZoomInfo sorprende con resultados mejores de lo esperado y sus acciones suben un 19,6%. Descubre qué otras acciones se están moviendo hoy.

Acciones de ZoomInfo se disparan un 20%; 20 acciones que se están moviendo en el premercado de EE.UU.

APPS

AVGR

BBAI

COHR

DGLY

FORM

MBRX

MTRX

PTIX

RANI

RXRX

SBET

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SLXN

SWKS

Coherent sorprende con sus resultados trimestrales y dispara sus acciones un 15,5%. ¿Qué otras empresas se mueven en el premercado de EE.UU.?

Acciones de Coherent (COHR) se disparan un 15%; 20 acciones que se mueven en el premercado de EE.UU.

Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Ginkgo Bioworks Holdings Inc

Metaverse Dualchain Network Architecture

DeNA Co Ltd

DNAPRINT GENOMICS INC by DNAPrint Genomics, Inc.

DNA Print Genomics Inc

DNA Brands Inc

Endeavour Silver Corp. ("Endeavour" or the "Company") (NYSE:<a href="https://www.benzinga.com/stock/EXK#NYSE">EXK</a>, TSX:<a href="https://www.benzinga.com/stock/EDR#TSX">EDR</a>) is pleased to announce that its wholly-owned subsidiary, Terronera Precious Metals, S.A. de C.V. (Terronera) has amended and restated the previously announced senior secured debt facility (the "Credit Facility") with ING Capital LLC (together with ING Bank N.V.) and Societe Generale acting as Joint Lead Arrangers. The Credit Facility was announced by press release on October 10, 2023.
Among other things, the Credit Facility was amended and restated to increase the principal amount of up to $120,000,000 by an additional $15,000,000, bringing the aggregate principal amount up to $135,000,000.
Proceeds from the Credit Facility will be used towards completing commissioning at the Company's Terronera Project in Jalisco state, Mexico and for general working capital purposes. All references to dollars ($) in this news release are in United States dollars.
As a condition to funding and a risk management strategy, Terronera has entered into zero cost collars to partially manage silver price exposure and cash flows over the next twelve months. With these zero cost collars, Terronera has protected the downside at $31.00 per ounce and will participate in any silver appreciation up to $42.00&nbsp;over that period for approximately 968,000 silver ounces.
Terronera commissioning activities are proceeding as planned and remain aligned with management's expectations. The Company will provide an update as it approaches the commencement of commercial production.

Endeavour Silver Boosts Credit Line to $135M to Support Mexico Mine Launch and Operations

UBS analyst Marcus Cole initiates coverage on Amrize (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMRZ#NYSE">AMRZ</a>) with a Neutral rating and announces Price Target of $53.

Price Target

Initiation

Analyst Ratings

AMRZ

UBS Initiates Coverage On Amrize with Neutral Rating, Announces Price Target of $53

XCF Global, Inc. ("XCF") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAFX#NASDAQ">SAFX</a>), a key player in decarbonizing the aviation industry through Synthetic Aviation Fuel ("SAF"), today announced the launch of a strategic international expansion framework designed to accelerate the adoption of SAF through capital-efficient, regionally tailored partnerships.
XCF's international expansion strategy centers on its patent-pending site design, developed to enable efficient deployment, lower capital intensity, and scalability across borders. Combined with an operational blueprint and configurations, this modular facility platform empowers partners to bring new SAF capacity online quickly, efficiently, and at scale.

SAFX

XCF Global Launches Plan To Speed Up Clean Jet Fuel Worldwide With Fast-Build, Low-Cost Facilities

ZenaTech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) (FSE: 49Q) (BMV:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#BMV">ZENA</a>) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions,&nbsp;announces it has signed an offer to acquire a Virginia-headquartered land survey and civil engineering firm with operations in three states and expertise serving major US federal government agencies and regional infrastructure programs. Upon completion, this acquisition would mark ZenaTech's first entry into the states of Virginia, North Carolina, and South Carolina, accelerating the Company's expansion across the Southeast region of the US.

BMV:ZENA

ZENA

ZenaTech And Quantum Computing Solutions Sign Offer To Acquire Virginia-Based Surveying Firm Serving U.S. Federal And Regional Infrastructure Projects

Phio Pharmaceuticals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL&#xAE; gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present an update on the company's proprietary INTASYL siRNA technology and progress on the on-going clinical trial with lead compound PH-762 for treatment of skin cancers. Recently, positive interim safety and efficacy results were reported in the on-going Phase 1b dose escalation clinical trial with the INTASYL compound PH-762 for the treatment of skin cancer.
Phio's presentation and live Q&amp;A will take place on Monday, June 30, 2025, at 10:00 am EST in the live Virtual Non-Deal Roadshow Series hosted by Renmark Financial Communications Inc. A replay of the event may be accessed on the Renmark Financial Communications Inc. website at <a href="https://api.newsfilecorp.com/redirect/jNo4riLBwn">https://www.renmarkfinancial.com/vndrs</a>.

PHIO

1. Phio Pharma CEO To Present New Skin Cancer Data On Groundbreaking Gene-Silencing Therapy PH-762

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXRX#NASDAQ">LXRX</a>) with a Buy and maintains $4 price target.

Reiteration

LXRX

HC Wainwright & Co. Reiterates Buy on Lexicon Pharmaceuticals, Maintains $4 Price Target

The Global Advisory Board brings together renowned business leaders to advise, guide and champion Endava's leadership position within the technology industry
Endava (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>), a leading business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announces the formation of its global advisory board.
Following 18 months of embedding AI across its own operations and collaborating with strategic partners and clients to drive AI-powered business outcomes, Endava has formed a prestigious group of advisors and ambassadors to help Endava in aiding the world's leading companies harness the power of AI to achieve transformative results.

DAVA

Endava Announces Formation Of Its Global Advisory Board

IXHL

Incannex Appoints Sleep Medicine Expert Douglas Kirsch To Advisory Board As IHL-42X OSA Program Nears Phase 2 Data Readout

OSTX

OS Therapies Receives FDA Feedback On Accelerated Approval Pathway For OST-HER2 In Pediatric Lung Metastatic Osteosarcoma; Seeks Breakthrough Therapy Designation

NKTR

Nektar's Rezpegaldesleukin Meets Primary And Key Secondary Endpoints In Phase 2b REZOLVE-AD Trial For Atopic Dermatitis, Showing Efficacy And Safety

Loop Capital analyst Anthony Chukumba downgrades Ollie's Bargain Outlet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>) from Buy to Hold and maintains the price target from $130 to $130.

Downgrades

OLLI

Loop Capital Downgrades Ollie's Bargain Outlet to Hold, Maintains Price Target to $130

XCHG Limited's XCharge NA Deploys Two Dual-Dispenser GridLink Chargers At Newly Launched EV Charging Depot In Riverside, California, Developed And Operated By Gateway Fleets

AeroVironment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) will release earnings results for the fourth quarter, after the <a href="https://www.benzinga.com/quote/AVAV/earnings">closing bell on Tuesday, June 24.</a>
Analysts expect the Arlington, Virginia-based company to report quarterly earnings at $1.42 per share on revenue of $242.69 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On June 18, AeroVironment and UAS Denmark announced a strategic partnership to advance allied UAS capabilities in Europe.
AeroVironment shares gained 0.8% to close at $191.23 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/avav/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Baird analyst Peter Arment maintained an Outperform rating and raised the price target from $146 to $210 on June 6, 2025. This analyst has an accuracy rate of 84%.</li>
<li>RBC Capital analyst Ken Herbert reinstated an Outperform rating with a price target of $190 on May 12, 2025. This analyst has an accuracy rate of 74%.</li>
<li>BTIG analyst Andre Madrid reiterated a Buy rating with a price target of $245 on Sept. 17, 2024. This analyst has an accuracy rate of 73%.</li>
<li>Raymond James analyst Brian Gesuale downgraded the stock from Outperform to Market Perform on Sept. 17, 2024. This analyst has an accuracy rate of 74%.</li>
<li>Alembic Global analyst Peter Skibitski upgraded the stock from Neutral to Overweight with a price target of $216 on Aug. 28, 2024. This analyst has an accuracy rate of 73%</li>
</ul>
Considering buying AVAV stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/avav/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="574" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24030520/image-346-1024x574.png" alt="" class="wp-image-959192" style="width:674px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24030520/image-346-1024x574.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24030520/image-346-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24030520/image-346-768x431.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24030520/image-346.png 1145w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/06/46050117/wall-streets-most-accurate-analysts-give-their-take-on-3-tech-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Tech Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Earnings

AVAV

Top Wall Street Forecasters Revamp AeroVironment Expectations Ahead Of Q4 Earnings

Acacia Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, today announced the appointment of Michael Zambito as Chief Financial Officer, effective June 24, 2025. Kirsten Hoover, Acacia's current Interim Chief Financial Officer, will continue to serve as Acacia's Controller and remains a key member of Acacia's finance team.
Prior to joining Acacia, Mr. Zambito spent the past 30 years at Ernst &amp; Young, a multinational professional services firm, and a global leader in assurance, tax, transactions, and consulting services. Most recently, he spent over 23 years, including the last 17 as a Partner, in Ernst &amp; Young's EY-Parthenon (formerly Strategy and Transactions) practice, a market-leading strategy, transactions, and corporate finance provider. Prior to this, he spent seven years in Ernst &amp; Young's NY audit practice, as staff through manager. Mr. Zambito received his MBA from Columbia Business School and holds a Bachelor of Science degree in Business Administration with a major in Accounting from the University of Richmond.

Management

ACTG

Acacia Appoints EY Veteran Michael Zambito as CFO, Former Interim CFO Kirsten Hoover Stays On as Controller

Macro Economic Events

Politics

Global

Economics

General

iShares MSCI Israel Capped Investable Market Index Fund

President Trump Posts On Truth Social: 'IRAN WILL NEVER REBUILD THEIR NUCLEAR FACILITIES!'

OPRX

OptimizeRx Appoints CEO Steve Silvestro To Board Of Directors To Strengthen Leadership And Advance Strategic Growth Plans

President Trump On Truth Social Posts: 'ISRAEL is not going to attack Iran. All planes will turn around and head home, while doing a friendly "Plane Wave" to Iran. Nobody will be hurt, the Ceasefire is in effect! Thank you for your attention to this matter! DONALD J. TRUMP, PRESIDENT OF THE UNITED STATES'

WhatsApp&nbsp;has emerged as a key arena for AI chatbot competition, reportedly posing a potential challenge to&nbsp;Meta Platforms Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) AI dominance.
What Happened: WhatsApp, with over 3 billion global users, has become a prime platform for various AI chatbots, including those from OpenAI and Perplexity, alongside Meta&#8217;s own assistant, <a href="https://www.businessinsider.com/meta-ai-competition-whatsapp-chatbot-battleground-2025-6">reported</a> Business Insider. This intense competition could potentially hinder Meta AI&#8217;s goal of becoming the default choice for its billions of users.
Notably, in the April earnings call, Meta&#8217;s CEO, Mark Zuckerberg, revealed that WhatsApp is &#8220;the&nbsp;largest surface that people use&nbsp;Meta AI on.&#8221;
WhatsApp, a primary battleground for consumer AI, is witnessing a surge in rival chatbots vying for user attention. Despite Meta AI being integrated into WhatsApp, the app&#8217;s strong usage continues.
OpenAI, which brought ChatGPT to WhatsApp last year, is working to make AI more widely accessible. Meanwhile, Perplexity&#8217;s chatbot, launched on WhatsApp this spring, experienced such overwhelming demand at launch that it briefly crashed.
These competing chatbots utilize the WhatsApp Business Platform, allowing them to reach WhatsApp&#8217;s vast global audience without requiring Meta&#8217;s direct approval. This is particularly beneficial in emerging markets&nbsp;such as India and Brazil, where&nbsp;WhatsApp is a primary communication tool.
Meta did not immediately respond to <a href="http://pro.benzinga.com">Benzinga&#8217;s</a> request for comment.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/23/06/33000234/california-democrat-ro-khanna-questions-feds-2-inflation-target-why-is-it-sacrosanct-as-opposed-to-s" target="_blank" rel="noreferrer noopener">Ro Khanna Wants To Know Why Fed's 2% Inflation Target Is &#8216;Sacrosanct&#8217; &#8211; Benzinga</a>
Why It Matters: The rise of AI chatbots on WhatsApp comes at a time when Meta is facing challenges. Just a day before this report,&nbsp;WhatsApp was banned on<a href="https://www.benzinga.com/markets/tech/25/06/46066338/whatsapp-blocked-on-us-house-devices-over-transparency-encryption-concerns-meta-app-deemed-high-risk-while-imessage-facetime-and-teams-get-green-light"> U.S. House</a> devices&nbsp;over transparency and encryption concerns, further complicating Meta&#8217;s position.
However, Meta&#8217;s WhatsApp is not without its potential. An analyst recently estimated that Meta could potentially generate over <a href="https://www.benzinga.com/markets/tech/25/06/45969694/mark-zuckerbergs-meta-could-rake-in-over-10-billion-in-annual-ad-revenue-from-whatsapp-by-2028-says-analyst">$10 billion</a> in annual ad revenue from its&nbsp;WhatsApp messaging service by 2028, indicating that the platform still holds significant value for the company.
Benzinga's Edge Rankings place Meta Platforms in the 85th percentile for momentum and the 28th percentile for value, reflecting its strong performance in both areas. Check the detailed report <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a>.&nbsp;
On a year-to-date basis, Meta stock surged 16.57%, according to data from <a href="http://pro.benzinga.com">Benzinga Pro.</a>
<ul class="wp-block-list">
<li>READ MORE: <a href="https://www.benzinga.com/markets/tech/25/06/46050532/mark-zuckerbergs-maga-pivot-driven-by-elon-musk-envy-image-goals-say-betrayed-meta-insiders-report">Mark Zuckerberg&#8217;s MAGA Pivot Driven By Elon Musk Envy, Image Goals, Say &#8216;Betrayed&#8217; Meta Insiders: Report</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Mark Zuckerberg's AI Dreams Hit WhatsApp Speed Bump As OpenAI, Perplexity Challenge Meta On Its Own Turf: Report

Digital Asset, the developer behind the Canton Network, has raised $135 million in a funding round backed by major Wall Street players <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42047066/goldman-sachs-to-spin-out-digital-assets-platform-amid-blockchain-push">including Goldman Sachs</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) and Citadel Securities, alongside leading crypto investors.
The round, led by DRW Venture Capital and Tradeweb Markets, signals growing institutional confidence in blockchain solutions designed for traditional finance.
The new capital will <a href="https://www.prnewswire.com/news-releases/digital-asset-raises-135-million-to-accelerate-adoption-of-canton-network-302488899.html">accelerate</a> the onboarding of real-world assets onto the Canton Network, which Digital Asset describes as the first public, permissionless Layer-1 blockchain offering configurable privacy for institutional use.
The network already supports a broad range of assets, including bonds, commodities, repos, mortgages, and alternative funds.
Other participants in the round include BNP Paribas, Circle Ventures, The Depository Trust &amp; Clearing Corporation (DTCC), IMC, Liberty City Ventures, Optiver, Paxos, Polychain Capital, QCP, Republic Digital, 7RIDGE and Virtu Financial.
Also Read: <a href="https://www.benzinga.com/markets/tech/25/06/46055372/new-crypto-fund-targets-early-builders-is-this-where-the-next-blockchain-unicorn-starts">New Crypto Fund Targets Early Builders: Is This Where The Next Blockchain Unicorn Starts?</a>
Goldman Sachs' Mathew McDermott said, "Our longstanding relationship with Digital Asset stems from a deep conviction in the strength of their technology, which continues to be foundational to the development and ongoing success of GS DAP."
Don Wilson, CEO of DRW, emphasized the maturity of the market, stating, "We are at the inflection point of being able to use blockchain at scale in traditional markets."
The funding is set to bolster Canton&#8217;s position as a blockchain protocol tailored for regulated institutions, offering privacy controls that have long been a barrier to enterprise blockchain adoption. 
Digital Asset says Canton already has nearly 400 participants within its ecosystem, reflecting momentum among both traditional and decentralized finance players.
Digital Asset CEO Yuval Rooz added, "This funding milestone validates the inevitability of what we envisioned years ago: a privacy-enabled public blockchain designed specifically for institutional adoption."
The Canton Network enables asset synchronization across financial markets with an emphasis on real-time, private, and interoperable settlement, a feature that its backers see as a step toward modernizing financial infrastructure.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46053180/sequans-takes-a-page-from-microstrategy-is-bitcoin-the-new-corporate-treasury-play">Sequans Takes A Page From MicroStrategy: Is Bitcoin The New Corporate Treasury Play?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

What's Driving Goldman Sachs And Citadel Into Crypto? The $135M Digital Asset Funding Round Explained

Macquarie analyst Aditya Suresh upgrades MakeMyTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) from Neutral to Outperform and announces $110 price target.

Upgrades

MMYT

Macquarie Upgrades MakeMyTrip to Outperform, Announces $110 Price Target

Press Releases

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results

Stem Cell Stocks on the Rise: Companies Driving the $48 Billion Market Boom

Contracts

Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain

Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation

Commodities

Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation

Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors

Ginkgo Bioworks Reports First Quarter 2025 Financial Results

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

4 Stocks To Watch In The $47 Billion Cellular Therapeutics Market

Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer

ADIA

FATE

PLUR

TWST

Alto Ingredients

Ashland

ASP Isotopes

Aspen Aerogels

Avient

Bon Natural Life Limited - Class A Ordinary Shares

Bon Natural Life

Ecovyst

Flexible Solutions International Inc. Common Stock (CDA)

Flexible Solutions Intl

Flotek Industries

H.B. Fuller

Innospec

Quaker Houghton

Minerals Technologies

Ingevity

Northern Technologies International Corporation - Common Stock

Northern Technologies

Perimeter Solutions

Rayonier Advanced Materials Inc. Common Stock

Rayonier Adv Materials

Stepan

Solesence

Sensient Technologies Corporation Common Stock

Sensient Technologies

Valhi

TD Cowen

BTIG

Goldman Sachs

Morgan Stanley

Genentech

Comments

Ginkgo Bioworks Holdings

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL